FAFatma Akyel

Fatma Akyel

*This is an algorithmically generated author record based on publicly available information.

Fatma Akyel has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Exploring vestibular dysfunction in primary hypothyroidism using cervical vestibular evoked myogenic potentials

    by Ayhan Kars, Fatma Atalay, Kübra Topal, Sezai Sacid Anbar, Fatma Akyel, Korhan Kılıç

    Purpose: This research was conducted to assess cervical vestibular evoked myogenic potential (cVEMP) test responses in patients with primary hypothyroidism without vestibular symptoms. Materials and Methods: Thirty-one patients diagnosed with primary hypothyroidism and who had not yet started on hormone replacement therapy, together with a 26-member control group, were enrolled in the research. All participants underwent detailed otorhinolaryngological examinations and thyroid function, cVEMP, and audiological tests. cVEMP records were compared between the groups. Results: Thirty-one patients aged between 21 and 57 years (38.5±9.7) and a control group of 26 healthy volunteers aged between 20 and 52 years (36.1±8.8) were included in the study. Absent VEMP responses were observed in 12 members of the patient group and in three of the control group. Interpeak amplitudes (IPAs) in both ears were significantly lower in the patient group than in the controls. While no significant difference was found between the groups’ VEMP threshold values, asymmetry rates in both ears were significantly higher in the patient group. Conclusion: cVEMP can be usefully employed in the detection of subclinical

  • Multiorgan dysfunction due to colchicine

    by Miraç Koç, Hatice Karabulut, Özgür Önen, Fatma Akyel, Fatma Mutlu Kukul Güven

    Colchicine is used in the treatment of many diseases. It should be used very carefully as the treatment dose and toxic dose are very close to each other and may lead to multiorgan failure. Although colchicine toxicity is usually seen in suicidal use, it may also occur when used in therapeutic doses. In this report, we present a case of a 70-year-old patient who used colchicine due to pericardial effusion over two months and died from multiorgan failure, to draw attention to colchicine toxicity due to using it in therapeutic doses.